Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Loa Loa (eye worm) | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Echinococcus multilocularis | Glycosyl transferase, family 35 | 0.0244 | 0.5 | 0.5 |
Echinococcus granulosus | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0244 | 0.5 | 0.5 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0244 | 0.5 | 0.5 |
Chlamydia trachomatis | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Echinococcus granulosus | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Entamoeba histolytica | glycogen phosphorylase, putative | 0.0244 | 0.5 | 0.5 |
Schistosoma mansoni | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Trichomonas vaginalis | glycogen phosphorylase, putative | 0.0244 | 0.5 | 0.5 |
Echinococcus multilocularis | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Onchocerca volvulus | Glycogen phosphorylase homolog | 0.0244 | 0.5 | 0.5 |
Echinococcus granulosus | Glycosyl transferase family 35 | 0.0244 | 0.5 | 0.5 |
Schistosoma mansoni | glycogen phosphorylase | 0.0244 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 23.9 % | Analgesic activity in mouse assessed as protection against phenylquinone-induced writhes at 50 mg/kg, po administered 1 hr before phenylquinone challenge relative to control | ChEMBL. | 18289736 |
ALD50 (ADMET) | > 800 mg kg-1 | Acute toxicity in ip dosed albino mouse assessed as mortality after 24 hrs | ChEMBL. | 18289736 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.